These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15157383)

  • 1. [Myasthenia gravis in children: clinical study of 77 patients].
    Zhou SZ; Li WH; Sun DK
    Zhonghua Er Ke Za Zhi; 2004 Apr; 42(4):256-9. PubMed ID: 15157383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical characteristics and follow-up management of 135 children with myasthenia gravis].
    Yang ZX; Xiong H; Zhang YH; Bao XH; Jiang YW; Wu Y; Wang S; Chang XZ; Qin J; Lin Q; Wu XR
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):455-9. PubMed ID: 21681282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and electrophysiological peculiarities of seronegative myasthenia].
    Shcherbakova NI; Sanadze AG; Sidnev DV; Rudnichenko VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(3):4-10. PubMed ID: 18427534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of thymectomy on seronegative generalized myasthenia gravis: comparing with seropositive cases.
    Yuan HK; Huang BS; Kung SY; Kao KP
    Acta Neurol Scand; 2007 Mar; 115(3):181-4. PubMed ID: 17295713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
    Kupersmith MJ; Latkany R; Homel P
    Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylcholine receptor antibodies in myasthenia gravis are associated with greater risk of diabetes and thyroid disease.
    Toth C; McDonald D; Oger J; Brownell K
    Acta Neurol Scand; 2006 Aug; 114(2):124-32. PubMed ID: 16867036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
    Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
    Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Seronegative myasthenia gravis].
    Bilińska M
    Pol Merkur Lekarski; 2002 Jan; 12(67):49-53. PubMed ID: 11957803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological and clinical features of patients with myasthenia gravis in north Indian population.
    Suhail H; Subbiah V; Singh S; Behari M
    Int J Neurosci; 2010 Feb; 120(2):115-9. PubMed ID: 20199203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different characteristic phenotypes according to antibody in myasthenia gravis.
    Oh SJ; Morgan MB; Lu L; Hatanaka Y; Hemmi S; Young A; Claussen GC
    J Clin Neuromuscul Dis; 2012 Dec; 14(2):57-65. PubMed ID: 23172384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological follow-up in juvenile myasthenia: clinical and acetylcholine receptor antibody status of patients followed for at least 2 years.
    Anlar B; Senbil N; Köse G; Değerliyurt A
    Neuromuscul Disord; 2005 May; 15(5):355-7. PubMed ID: 15833428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do acetylcholine receptor and striated muscle antibodies predict the presence of thymoma in patients with myasthenia gravis?
    Choi Decroos E; Hobson-Webb LD; Juel VC; Massey JM; Sanders DB
    Muscle Nerve; 2014 Jan; 49(1):30-4. PubMed ID: 23625360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between anti-acetylcholine receptor antibody titres and severity of myasthenia gravis.
    Aurangzeb S; Tariq M; Irshad M; Badshah M; Khan RS
    J Pak Med Assoc; 2009 May; 59(5):289-92. PubMed ID: 19438131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-alkaline phosphatase antibody positive myasthenia gravis.
    Konishi T; Ohta K; Shigemoto K; Ohta M
    J Neurol Sci; 2007 Dec; 263(1-2):89-93. PubMed ID: 17628604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of seropositive myasthenia gravis in Cape Town and South Africa.
    Bateman KJ; Schinkel M; Little F; Liebenberg L; Vincent A; Heckmann JM
    S Afr Med J; 2007 Oct; 97(10):959-62. PubMed ID: 18000579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Measurement of acetylcholine receptor antibodies in serum of patients with myasthenia gravis].
    Bilińska M; Dobrzyńska L; Hebel R; Szutowicz A
    Neurol Neurochir Pol; 1999; 32 Suppl 6():167-73. PubMed ID: 11107583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MuSK antibody-positive, seronegative myasthenia gravis in Korea.
    Lee JY; Sung JJ; Cho JY; Oh DH; Kim HJ; Park JH; Lee KW; Choi YC; Vincent A
    J Clin Neurosci; 2006 Apr; 13(3):353-5. PubMed ID: 16546389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myasthenia gravis in Jamaican children: a 12-year institutional review.
    Melbourne Chambers R; Forrester S; Gray R; Tapper J; Trotman H
    Paediatr Int Child Health; 2012 Feb; 32(1):47-50. PubMed ID: 22525448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile myasthenia gravis: a twenty-year experience.
    Castro D; Derisavifard S; Anderson M; Greene M; Iannaccone S
    J Clin Neuromuscul Dis; 2013 Mar; 14(3):95-102. PubMed ID: 23492460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.